Skip to content

WALLSTENT™ RP Endoprosthesis M001711350Recalls & reported problems

Boston Scientific Corporation · Self-Expanding Stent · Class 2 · Implant

All models of WALLSTENT RP Endoprosthesis (19)

Data updated Oct 18, 2026 from official FDA records · Editorial policy

Adverse event reports
1
Deaths reported
0
Injuries reported
0
Recalls naming it
0

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 08714729406464), received between Feb 20, 2023 and Feb 20, 2023 — classified as 1 malfunction.

The most frequently reported specific device problem is “Break” (1 report).

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Device problems

  • Break1

Patient problems

  • No Clinical Signs, Symptoms or Conditions1

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

  • MalfunctionFeb 20, 2023Break; Break

    IT WAS REPORTED THAT SHAFT BREAK OCCURRED. THE PATIENT UNDERWENT POST TRANSJUGULAR INTRAHEPATIC PORTOSYSTEMIC SHUNT FOR THE TREATMENT OF LARGE VOLUME CLOT IN THE MAIN EXTRAHEPATIC PORTAL SUPERIOR MESENTERIC VEIN AND SPLENIC CONFLUENCE EXTENDING INTO THE RIGHT PORTAL VEIN. A 10X42X135/ 7F REDUCED PROFILE WALLSTENT RP ENDOPROSTHESIS WAS SELECTED TO TREAT THE LESION. HOWEVER, THE DEVICE WAS FOUND TO BE BROKEN PROXIMAL TO THE HUB. THERE WERE NO PATIENT COMPLICATIONS REPORTED.

    Patient problems: No Clinical Signs, Symptoms or Conditions

    MAUDE report 16404935 ↗

Other Prosthesis, tracheal, expandable devices

All Prosthesis, tracheal, expandable devices →

Sources and updates

How reports and recalls are matched · Editorial policy · Report an error on this page